fda glp-1 compounding enforcement september 2025 is short-sighted on GLP-1s FDA issued 25 warning letters
Description
Muller DRP, Stenvers DJ, Malekzadeh A, et al
In the STEP 1 trial, about 10% of participants achieved less than 5% weight loss, roughly the same as placebo response
Discover the difference with our innovative patches
Rights and permissions This article is published under an open access license
